These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27986830)

  • 1. Subtle motor disturbances in PREDICT-PD participants.
    Noyce AJ; Schrag A; Masters JM; Bestwick JP; Giovannoni G; Lees AJ
    J Neurol Neurosurg Psychiatry; 2017 Mar; 88(3):212-217. PubMed ID: 27986830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease.
    Rodriguez-Blazquez C; Rojo-Abuin JM; Alvarez-Sanchez M; Arakaki T; Bergareche-Yarza A; Chade A; Garretto N; Gershanik O; Kurtis MM; Martinez-Castrillo JC; Mendoza-Rodriguez A; Moore HP; Rodriguez-Violante M; Singer C; Tilley BC; Huang J; Stebbins GT; Goetz CG; Martinez-Martin P
    Parkinsonism Relat Disord; 2013 Oct; 19(10):889-93. PubMed ID: 23791519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplified conversion method for unified Parkinson's disease rating scale motor examinations.
    Hentz JG; Mehta SH; Shill HA; Driver-Dunckley E; Beach TG; Adler CH
    Mov Disord; 2015 Dec; 30(14):1967-70. PubMed ID: 26779608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
    Goetz CG; Tilley BC; Shaftman SR; Stebbins GT; Fahn S; Martinez-Martin P; Poewe W; Sampaio C; Stern MB; Dodel R; Dubois B; Holloway R; Jankovic J; Kulisevsky J; Lang AE; Lees A; Leurgans S; LeWitt PA; Nyenhuis D; Olanow CW; Rascol O; Schrag A; Teresi JA; van Hilten JJ; LaPelle N;
    Mov Disord; 2008 Nov; 23(15):2129-70. PubMed ID: 19025984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age, Gender, Comorbidity, and the MDS-UPDRS: Results from a Population-Based Study.
    Keezer MR; Wolfson C; Postuma RB
    Neuroepidemiology; 2016; 46(3):222-7. PubMed ID: 26967747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale.
    Martínez-Martín P; Rodríguez-Blázquez C; Mario Alvarez ; Arakaki T; Arillo VC; Chaná P; Fernández W; Garretto N; Martínez-Castrillo JC; Rodríguez-Violante M; Serrano-Dueñas M; Ballesteros D; Rojo-Abuin JM; Chaudhuri KR; Merello M
    Parkinsonism Relat Disord; 2015 Jan; 21(1):50-4. PubMed ID: 25466406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calibration of unified Parkinson's disease rating scale scores to Movement Disorder Society-unified Parkinson's disease rating scale scores.
    Goetz CG; Stebbins GT; Tilley BC
    Mov Disord; 2012 Sep; 27(10):1239-42. PubMed ID: 22886777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the relationship between non-motor symptoms and health-related quality of life in Parkinson's disease: a retrospective observational cohort study.
    Ueno T; Kon T; Haga R; Nishijima H; Arai A; Tomiyama M
    Neurol Sci; 2020 Oct; 41(10):2867-2873. PubMed ID: 32328832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity.
    Hill EJ; Mangleburg CG; Alfradique-Dunham I; Ripperger B; Stillwell A; Saade H; Rao S; Fagbongbe O; von Coelln R; Tarakad A; Hunter C; Dawe RJ; Jankovic J; Shulman LM; Buchman AS; Shulman JM
    Parkinsonism Relat Disord; 2021 Mar; 84():105-111. PubMed ID: 33607526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of sleep-related symptoms on clinical motor subtypes and disability in Parkinson's disease: a multicentre cross-sectional study.
    Suzuki K; Okuma Y; Uchiyama T; Miyamoto M; Sakakibara R; Shimo Y; Hattori N; Kuwabara S; Yamamoto T; Kaji Y; Hirano S; Kadowaki T; Hirata K;
    J Neurol Neurosurg Psychiatry; 2017 Nov; 88(11):953-959. PubMed ID: 28847794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.
    Goetz CG; Fahn S; Martinez-Martin P; Poewe W; Sampaio C; Stebbins GT; Stern MB; Tilley BC; Dodel R; Dubois B; Holloway R; Jankovic J; Kulisevsky J; Lang AE; Lees A; Leurgans S; LeWitt PA; Nyenhuis D; Olanow CW; Rascol O; Schrag A; Teresi JA; Van Hilten JJ; LaPelle N
    Mov Disord; 2007 Jan; 22(1):41-7. PubMed ID: 17115387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between the Movement Disorders Society Unified Parkinson's Disease rating scale (MDS-UPDRS) and the Unified Parkinson's Disease rating scale (UPDRS) during L-dopa acute challenge.
    Merello M; Gerschcovich ER; Ballesteros D; Cerquetti D
    Parkinsonism Relat Disord; 2011 Nov; 17(9):705-7. PubMed ID: 21784692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the Progression of Parkinson's Disease MDS-UPDRS-III Motor Severity Score from Gait Data using Deep Learning.
    Zia Ur Rehman R; Rochester L; Yarnall AJ; Del Din S
    Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():249-252. PubMed ID: 34891283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments.
    Lang AE; Eberly S; Goetz CG; Stebbins G; Oakes D; Marek K; Ravina B; Tanner CM; Shoulson I;
    Mov Disord; 2013 Dec; 28(14):1980-6. PubMed ID: 24123383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teaching program for the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale: (MDS-UPDRS).
    Goetz CG; Stebbins GT; Chmura TA; Fahn S; Poewe W; Tanner CM
    Mov Disord; 2010 Jul; 25(9):1190-4. PubMed ID: 20629138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPES/SCOPA and MDS-UPDRS: formulas for converting scores of two motor scales in Parkinson's disease.
    Verbaan D; van Rooden SM; Benit CP; van Zwet EW; Marinus J; van Hilten JJ
    Parkinsonism Relat Disord; 2011 Sep; 17(8):632-4. PubMed ID: 21696993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.
    Regnault A; Boroojerdi B; Meunier J; Bani M; Morel T; Cano S
    J Neurol; 2019 Aug; 266(8):1927-1936. PubMed ID: 31073716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS).
    Martinez-Martin P; Rodriguez-Blazquez C; Alvarez-Sanchez M; Arakaki T; Bergareche-Yarza A; Chade A; Garretto N; Gershanik O; Kurtis MM; Martinez-Castrillo JC; Mendoza-Rodriguez A; Moore HP; Rodriguez-Violante M; Singer C; Tilley BC; Huang J; Stebbins GT; Goetz CG
    J Neurol; 2013 Jan; 260(1):228-36. PubMed ID: 22865238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting outcomes in Parkinson's disease: comparison of simple motor performance measures and The Unified Parkinson's Disease Rating Scale-III.
    Grill S; Weuve J; Weisskopf MG
    J Parkinsons Dis; 2011; 1(3):287-98. PubMed ID: 23939309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PREDICT-PD: identifying risk of Parkinson's disease in the community: methods and baseline results.
    Noyce AJ; Bestwick JP; Silveira-Moriyama L; Hawkes CH; Knowles CH; Hardy J; Giovannoni G; Nageshwaran S; Osborne C; Lees AJ; Schrag A
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):31-7. PubMed ID: 23828833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.